Martin Dreyling
机构: Professor of Medicine, University of Munich
每年引用次数
引用次数
引用: 50,014
H-指数: 101
I10-指数 : 406
出版物: 1,095
Severe Candida glabrata pancolitis and fatal Aspergillus fumigatus pulmonary infection in the setting of bone marrow aplasia after CD19-directed CAR T-cell therapy - a case report
Oliver Weigert , Louisa von Baumgarten , Marion Subklewe , Marion Subklewe
BMC Infectious Diseases 21 ( 1) 121 -121
16
2021
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic
Marie Jose Kersten , Kim Linton , Christian Buske , Mats Jerkeman
HemaSphere 5 ( 2)
9
2021
LRPAP1-autoantibodies in mantle cell lymphoma are associated with superior outcome.
Stephan Stilgenbauer , Eva Hoster , Natalie Fadle , Niels M Murawski
Blood
2021
Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma.
Pier Luigi Zinzani , Don Stevens , Arnon Nagler , George A Follows
Blood Advances 5 ( 3) 823 -828
18
2021
Efficacy and Safety of Tisagenlecleucel in Adult Patients with Relapsed/Refractory Follicular Lymphoma: Interim Analysis of the Phase 2 Elara Trial
Nathan H Fowler , Michael Dickinson , Martin Dreyling , Joaquin Martinez-Lopez
Transplantation and Cellular Therapy 27 ( 3)
2021
Indolent lymphomas: current and emerging treatment approaches.
Brad S Kahl , David Maloney , Martin Dreyling
Clinical advances in hematology & oncology 4 1
2
2006
Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial.
Mathias Haenel , Peter Borchmann , Norbert Schmitz , Fabian Frontzek
The Lancet Haematology 8 ( 4)
1
2021
CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma-Diagnostic, Therapeutic, and Prognostic Relevance.
Uwe Koedel , Markus Pfirrmann , Louisa Von Baumgarten , Barbara Angele
Frontiers in Neurology 12 654543 -654543
2021
Mantle cell lymphoma – advances in molecular biology, prognostication and treatment approaches
Kim Linton , Martin Dreyling , Elisabeth Silkenstedt
British Journal of Haematology
2021
CAR T-Cells for CNS Lymphoma: Driving into New Terrain?
Louisa von Baumgarten , Marion Subklewe , Joerg-Christian Tonn , Niklas Thon
Cancers 13 ( 10) 2503
2021
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma.
Martin Dreyling , Armando Santoro , Luigina Mollica , Sirpa Leppä
Journal of Clinical Oncology 35 ( 35) 3898 -3905
312
2017
Long-Term Efficacy and Safety of Copanlisib in Multiply Relapsed or Refractory Patients with Marginal Zone Lymphoma
Martin Dreyling , Panayiotis Panayiotidis , George A Follows , Luigina Mollica
Blood 134 1531 -1531
2
2019
Obinutuzumab (GA101) in Combination with Pixantrone for the Treatment of Patients with Relapsed Aggressive B-Cell Lymphoma:Â a Phase II Trial (GOAL)
Georg Hess , Andreas Hüttmann , Julia Meissner , Reinhard Marks
Blood 132 1678 -1678
1
2018
Behandlung follikulärer Lymphome
Roswitha Forstpointner , Martin Dreyling
Info Onkologie 18 ( 1) 30 -40
2015
ABCL-170: Long-Term Outcomes from the Phase II L-MIND Study of Tafasitamab (MOR208) Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Gilles Salles , Johannes Duell , Eva González-Barca , Wojciech Jurczak
Clinical Lymphoma Myeloma and Leukemia 20 S267 -S268
2020
Molecular Remission after Combined Immunochemotherapy Is of Prognostic Relevance in Patients with MCL: Results of the Randomized Intergroup Trials of the European MCL Network
Christiane Pott , Eva Hoster , Sebastian Böttcher , Reiner Siebert
Blood 112 ( 11) 582 -582
12
2008
Autologous Stem Cell Transplantation after Myeloablative Therapy in First Remission May Be Beneficial in Patients with Advanced Stage Follicular Lymphoma after Front-Line Therapy with R-CHOP. An Analysis of Two Consecutive Studies of the German Low Grade Lymphoma Study Group (GLSG)
Wolfgang Hiddemann , Christian Buske , Michael Kneba , Martin Dreyling
Blood 112 ( 11) 772 -772
9
2008
Inhibition of Protein Kinase C beta by Enzastaurin (LY 317615) Induces Alterations of Key Regulators of Cell Cycle and Apoptosis in Mantle Cell Lymphoma and Synergizes with Chemotherapeutic Agents in a Sequence Dependent Manner.
Grit Hutter , Yvonne Zimmermann , Marc Weinkauf , Wolfgang Hiddemann
Blood 106 ( 11) 2416 -2416
6
2005
Inhibition of Proteasome Is Associated with Early Alterations of Cell Cycle Regulators and Induces Synergistic Antitumour Activities in Mantle Cell Lymphoma in a Sequence Dependent Manner.
Alessandro Pastore , Malte Rieken , Oliver Weigert , Yvonne Zimmermann
Blood 106 ( 11) 2409 -2409
2
2005
ADAM10 releases the immunoregulator soluble TACI - A novel biomarker for B-cell pathologies
Franziska Hoffmann , Peer-Hendrik Kuhn , Sarah A. Laurent , Stefanie M. Hauck
Journal of Neuroimmunology 275 ( 1) 5 -6
2014